rs1057517786
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_007217.4(PDCD10):c.103C>T(p.Arg35*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PDCD10
NM_007217.4 stop_gained
NM_007217.4 stop_gained
Scores
3
3
1
Clinical Significance
Conservation
PhyloP100: 3.12
Genes affected
PDCD10 (HGNC:8761): (programmed cell death 10) This gene encodes an evolutionarily conserved protein associated with cell apoptosis. The protein interacts with the serine/threonine protein kinase MST4 to modulate the extracellular signal-regulated kinase (ERK) pathway. It also interacts with and is phosphoryated by serine/threonine kinase 25, and is thought to function in a signaling pathway essential for vascular developent. Mutations in this gene are one cause of cerebral cavernous malformations, which are vascular malformations that cause seizures and cerebral hemorrhages. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-167704889-G-A is Pathogenic according to our data. Variant chr3-167704889-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 372445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-167704889-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDCD10 | NM_007217.4 | c.103C>T | p.Arg35* | stop_gained | 4/9 | ENST00000392750.7 | NP_009148.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDCD10 | ENST00000392750.7 | c.103C>T | p.Arg35* | stop_gained | 4/9 | 1 | NM_007217.4 | ENSP00000376506.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1450956Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 722432
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1450956
Hom.:
Cov.:
26
AF XY:
AC XY:
0
AN XY:
722432
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 18, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 21, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 26896283, 23485406, 30161288, 25354366, 31254430, 23595507, 35883785, 18035376, 15543491) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | PDCD10: PVS1, PM2, PS4:Moderate - |
Cerebral cavernous malformation 3 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 07, 2023 | This sequence change creates a premature translational stop signal (p.Arg35*) in the PDCD10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PDCD10 are known to be pathogenic (PMID: 15543491, 18300272, 23801932). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with cerebral cavernous malformations (PMID: 15543491, 18035376, 23485406, 23595507, 26896283). This variant is also known as 30075cga-TGA stop. ClinVar contains an entry for this variant (Variation ID: 372445). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 03, 2023 | The PDCD10 c.103C>T; p.Arg35Ter variant (rs1057517786), also published as 30075cga-TGA stop, is reported in the literature in multiple individuals and families affected with cerebral cavernous malformations (Bergametti 2005, Bilo 2016, Fusco 2019, Lee 2008, Tsutsumi 2013). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Bergametti F et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 2005 Jan;76(1):42-51. PMID: 15543491. Bilo L et al. CCM3/PDCD10 gene mutation in cerebral cavernous malformations associated with hyperkeratotic cutaneous capillary venous malformations. J Dermatol. 2016 Aug;43(8):962-3. PMID: 26896283. Fusco C et al. Molecular diagnostic workflow, clinical interpretation of sequence variants, and data repository procedures in 140 individuals with familial cerebral cavernous malformations. Hum Mutat. 2019 Nov;40(11):e24-e36. PMID: 31254430. Lee ST et al. Identification of an Arg35X mutation in the PDCD10 gene in a patient with cerebral and multiple spinal cavernous malformations. J Neurol Sci. 2008 Apr 15;267(1-2):177-81. PMID: 18035376. Tsutsumi S et al. Genomic causes of multiple cerebral cavernous malformations in a Japanese population. J Clin Neurosci. 2013 May;20(5):667-9. PMID: 23485406. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2005 | - - |
Cerebral cavernous malformation Pathogenic:1
Pathogenic, no assertion criteria provided | research | Laboratory of Medical Genetics, University of Torino | Oct 06, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at